SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CRLS - Chrysalis : Any followers ? Any comments ?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sleepman who wrote (27)11/8/1997 6:31:00 PM
From: BulbaMan   of 51
 
My feeling is, based on their backlog, CRLS will begin making money soon. And, by my calculations, they had a positive cash flow last quarter (with depreciation and amortization of $708,000), although the EPS was a loss of a penny (-$93,000).
They had about $7.8 million in cash on 9/30/97, but CRLS is not a biotech that's burning cash but a going concern -- so, their cash position is pretty decent.
The future patent royalties are the big unknown -- but I think the stock is undervalued based just on CRLS's contract research business.
You might want to check out their SEC filings for more info.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News